BBLG — BONE BIOLOGICS CORP
As of Q2 2026, 1 SEC-registered investment managers reported holding BBLG (BONE BIOLOGICS CORP) in their latest 13F filings, with a combined reported value of $32.71K across 23.88K shares. That is +42541.1% by share count (+23.82K shares) versus the previous quarter, while reported value moved +52664.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BBLG is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q3 2024 | 28.53K | $60.76K | 0.00% | New |
| Vanguard Group history | Q3 2022 | 33.46K | $35.00K | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 23.88K | $32.71K | 0.00% | New |
| Geode Capital Management history | Q1 2025 | 24.20K | $19.36K | 0.00% | Add |
| Two Sigma Investments history | Q4 2025 | 11.08K | $16.07K | 0.00% | New |
| Citigroup Inc history | Q3 2025 | 206 | $575 | 0.00% | New |
| UBS Group AG history | Q1 2026 | 56 | $62 | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 14 | $20 | 0.00% | Hold |
| Wells Fargo & Co history | Q1 2024 | 4 | $9 | 0.00% | Hold |
| Millennium Management history | Q1 2023 | 17.82K | $5 | 0.00% | Reduce |
New Positions (Q2 2026)
- Citadel Advisors 23.88K sh · $32.71K
Fully Exited (vs previous quarter)
- UBS Group AG sold 56 sh · $62
Fund Position History — shares by quarter (top 10 funds)
| Fund | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 10.74K | — | — | — | — | — | 11.34K | — | — | — | — | — | — | — | — | 10.84K | — | 23.88K |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 11.08K | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | 9 | 14 | 20 | 21 | 4 | 14 | 14 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | 4.95K | — | — | 206 | — | — | — |
| UBS Group AG | 85 | 7.67K | — | 15.26K | 43.65K | — | 135 | — | 600 | 33.71K | 32.85K | 21.87K | — | 113 | 66 | 1.95K | 56 | — |
| Morgan Stanley | — | — | — | 10 | — | — | — | — | — | — | 28.53K | — | — | — | — | — | — | — |
| Geode Capital Management | — | — | — | — | — | — | 16.01K | — | — | — | — | 15.36K | 24.20K | — | — | — | — | — |
| Millennium Management | — | — | — | 47.07K | 17.82K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | 33.46K | 33.46K | 33.46K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | — | — | 21 | 47 | 52 | 2 | 23 | 4 | 4 | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details